ResearcherJiangsu Cancer HospitalActive in the last 2 years

Xiaodong Xie

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

[Retracted] Fe3O4‑solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. Co-author DOI 10.3892/ijo.2024.5657 ↗
Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. Co-author DOI 10.3892/ijo.2018.4637 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenrong Shen · 2 shared papers, 2019–2024 · strength 0.33
- Paper [Retracted] Fe3O4‑solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. DOI 10.3892/ijo.2024.5657 ↗
- Paper Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. DOI 10.3892/ijo.2018.4637 ↗
Lei Zhang · 1 shared paper, 2024 · strength 0.23
- Paper [Retracted] Fe3O4‑solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. DOI 10.3892/ijo.2024.5657 ↗
Lei Zhang · 1 shared paper, 2019 · strength 0.10
- Paper Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. DOI 10.3892/ijo.2018.4637 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.